| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62bf2c8e3be7f282db6e658eb393bed1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
| filingDate |
2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95567b0fca673932e0718b0aa6a001ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b23d38b79ed56112f741db7ce6d4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b295d2c22c68429d8e3f4fee6795513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1370e89f685930c5fe177ddbfa08e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b5381d52f22989d607173e810001758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff2ffb1aa6e6d25523f1192ffdeba22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af4644f0484bc34a094ca73b5631b74 |
| publicationDate |
2017-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017081688-A1 |
| titleOfInvention |
Optimized method for decontaminating production of glucose polymers and glucose polymer hydrolyzates |
| abstract |
The present invention relates to a method for decontaminating glucose polymers or the hydrolysates of the pro-inflammatory molecules thereof. Said method includes a) providing glucose polymers or the hydrolysates thereof, b) optionally, detecting or assaying the pro-inflammatory molecules in the glucose polymers or the hydrolysates thereof provided in Step a), and c) carrying out the following purifying steps: i. treatment using an enzymatic preparation having detergent properties and clarification properties; ii. treatment using a pharmaceutical-grade activated carbon with very high adsorption properties and “micropore” porosity; iii. optionally, treatment using a second activated carbon with “mesopore” porosity; iv. passing them over a macroporous adsorbent polymer resin having porosity greater than 100 Angstroms; and v. continuous ultrafiltration at 5 kDa. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018148754-A1 |
| priorityDate |
2014-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |